Motivation: Genes showing congruent differences in several genomic variables between two biological conditions are crucial to unravel causalities behind phenotypes of interest. Detecting such genes is important in biomedical research, e.g. when identifying genes responsible for cancer development. Small sample sizes common in next-generation sequencing studies are a key challenge, and there are still only very few statistical methods to analyze more than two genomic variables in an integrative, model-based way. Here, we present a novel bioinformatics approach to detect congruent differences between two biological conditions in a larger number of different measurements such as various epigenetic marks or mRNA transcript levels. Results: We propose a coefficient quantifying the degree to which genes present consistent alterations in multiple (more than two) genomic variables when comparing samples presenting a condition of interest (e.g. cancer) to a reference group. A hierarchical Bayesian model is employed to assess uncertainty on a gene level, incorporating information on functional relationships between genes. We demonstrate the approach on different data sets containing RNA-seq gene transcripton and up to four ChIP-seq histone modification measurements. Both the coefficient-based ranking and the inference based on the model lead to a plausible prioritizing of candidate genes when analyzing multiple genomic variables. Availability and implementation: BUGS code in the Supplement. Contact: m.schaefer@uni-duesseldorf.de
Introduction
A central goal in molecular biological research is to unravel causalities in the development of diseases such as cancer and to identify putative therapeutic drug targets. To shed light on the transcriptional regulatory mechanisms underlying a disease in this context, it is crucial to study the epigenome in addition to gene transcription and to identify genes presenting characteristic differences in specific epigenetic marks that are in congruence with transcriptional changes. Comparing disease-related tissues to appropriate control tissues is essential to warrant biological relevance, filtering out noise and unwanted effects such as GC content influence (Chung et al., 2013; Rozowsky et al., 2009) . The likelihood of a gene for playing an important role in the development of a disease is large when differences between the conditions show congruence between different relevant data types, growing with the number of integrated data sources. Post-translational modifications of histone proteins are an example for an epigenetic mechanism to regulate gene transcription that is fundamental to stem cell differentiation as well as to the genesis of cancer (Baylin and Jones, 2011; Dawson and Kouzarides, 2012) . Further mechanisms that can be measured genome-wide and incorporated in an integrative analysis include transcription factor binding, DNA methylation or non-coding RNA transcription.
Challenges in this context are to find an appropriate way to relate a growing number of variables in a modeling framework and to accomplish statistical inference on a gene level based on a small number of samples, common in sequencing experiments. To cope with small sample sizes, popular strategies are to reduce the need for information by restricting the parameter space and to borrow additional information from genes presenting a similar behavior. Both strategies have been explored to analyze single genomic inputs (see, e.g. Anders and Huber, 2010; Robinson et al., 2010) .
One promising path to carry out the latter strategy is to let functionally similar genes share their information, allowing the analysis of the regulatory networks behind a disease, rather than just particular genes. For this end, one may exploit numerous works publishing functional similarities between genes via pathway information or functional genomic networks directly quantifying the similarity between one gene and another. In a frequentist statistical framework, e.g., many authors employ network-based penalties in penalized regression models (e.g. Huang et al., 2011; Kim et al., 2013; Li and Li, 2008; Li et al., 2010; Pan et al., 2010) . In a Bayesian context, Brisbin and Fridley (2013) compare modeling strategies to relate the correlation between genes to the pathway structure, including conditionally autoregressive (CAR) Markov random field priors (correlation between neighbors in a defined sense) and models assuming that correlation between genes depends on the path length between them (e.g. spatial power and Gaussian decay models).
The CAR prior, common in spatial epidemiology (Besag et al., 1991) , has become one of the most pursued strategies to incorporate functional gene information. It can be viewed as a Bayesian interpretation of a frequentist network-constrained estimation approach (Pan et al., 2010) . Hu et al. (2011) , e.g., use a CAR prior to represent correlation between base-specific RNA-seq signals, Chen et al. (2011) to take pathway information into account in genome-wide association studies assessing the impact of genetic variants on diseases. Stingo and Vannucci (2011) and Tai et al. (2010) pursue the same strategy in the context of variable selection in linear regression models predicting clinical outcomes from gene transcription data. Instead of using a fixed network, Zhou and Zheng (2013) and Peterson et al. (2016) infer (or update) a network of regression predictors via a graphical model within a unifying framework, but their applications are limited to a moderate number of genes or proteins. Most of these approaches use a regression framework, modeling the associations between several genomic variables. To assess the degree to which differences between two biological conditions show congruence across several data sources, we propose to first condense the information from a number of different sources to a single score (building on previous works integrating two genomic variables without additional information, see Klein et al., 2014; Sch€ afer et al., 2009 ) and then apply a hierarchical Bayesian model. In this way, the differences between the relevant conditions do form the model's key variable. Resulting estimates can thus be used to rank genes in addition to classify genes as differential in several data sources.
Our model employs an intrinsic CAR prior to incorporate information from a network representing functional similarity between genes by a quantitative score. To our knowledge, existing approaches incorporating information about functional similarities are restricted to one or two genomic variables in addition to the phenotype variable (such as Wei and Pan, 2008 , who employ a CAR prior to integrate gene transcription and ChIP-chip transcription factor data). The innovation of our approach, which we call MARIO (MArkov Random fields to Integrate Omics variables) lies in linking a phenotype and multiple, i.e. more than two molecular biological variations with a functional genomic network in a comprehensive model-based framework based on a small number of samples. We demonstrate our model's advantages over a separate analysis on simulated data as well on two experimental data sets, integrating gene transcription RNA-seq data with several histone modification ChIP-seq data.
Our new method MARIO is presented in Section 2. In Section 3, two different data sets, the data matching and a simulation study are described. Section 4 gives a description of results obtained on these data, followed by a discussion in Section 5 and final conclusions in Section 6.
Materials and methods

Coefficient for integration of multiple genomic variates
For the analysis of multiple genomic variables, we propose a correlation coefficient Z that extends coefficients measuring externally centered correlation proposed by Sch€ afer et al. (2009 Sch€ afer et al. ( , 2012 and Klein et al. (2014) for the analysis of two types of genomic variables. Generalizing two-way correlation measures for a higher number of variables, the new coefficient condenses the biologically relevant information of several genomic variables by multiplying the absolute standardized differences of their values from the two compared collectives (e.g. cancer vs. control cells).
where X . . . ; m, if applicable. When comparing more than two variables, the sign of Z i does no longer reveal whether the differences between the two collectives are congruent in all variables. To preserve this desirable feature, the absolute value is multiplied by a factor S i 2 fÀ1; 1g ensuring that each summand of Z i has a positive sign for those genes for which all considered variables are biologically congruent. The variances of the differences r for a gene i are biologically consistent (i.e., in most cases, if they have the same sign) in all variables k ¼ 1 . . . ; K, the corresponding Z i value is positive, whereas it is negative in all other cases. If a gene does not have differences in all data types or has no differences at all, Z i is expected to be close to zero.
Hierarchical Bayesian model
Model
To perform inference on a gene level, we propose a model that borrows information across genes by assuming that functionally related genes are correlated w.r.t. the degree of congruence of differences in several genomic variables between two biological conditions. Similarity information is based on network-based similarity scores x ij for each edge between a gene i and a gene j in the network, taken from published genomic networks. The Z i are assumed to be normally distributed and the means for the normal distributions are represented by an auto-normal model (Besag et al., 1991) with a spatially structured component U i given an intrinsic Gaussian CAR prior. The similarity values from the genomic network are employed as weights in the CAR prior, for which the conditional mean given the neighbors may be specified as a weighted mean across the neighbors,
and d i representing a set of e n i genes neighboring i, where the term 'neighbor' in this context refers to functional rather to spatial proximity. Further, a l is assigned an improper flat prior on R, and the variance e v 2 is assigned an inverse Gamma distribution, i.e.
The posterior distributions of the normal means l i ; i ¼ 1; . . . ; n; are used to classify genes as 'differential', i.e. as presenting congruent differences between two biological conditions in several variables. In particular, gene i will be assumed to be differential if the 98% credible interval for l i lies above zero, favoring a conservative gene prioritizing.
Prior elicitation
The hyperparameters of the distributions for 1=r 2 i and 1=e v 2 are important as they regulate the degree of confidence in both the genelevel data and the functional similarities between genes reported by the network at hand. An empirical Bayesian approach is pursued for their determination, i.e. in this case, an empirical variance is examined in order to choose a prior for a theoretical one in the model. Specifically, to define the parameters for the gamma distributions for 1=e v 2 , we assume
where
Equation (4) is solved for e v 2 to obtain a mean value for this quantity. A prior variance of 10 4 is assumed for 1=e v 2 . Then, the gamma hyperprior in (3) is calculated using that EðXÞ ¼ a=b and VarðXÞ ¼ a=b 2 for X $ Gammaða; bÞ (Gilks et al., 1996) .
For 1=r 2 i , the mean for the prior distribution is chosen as 1=medianðe v 2 i Þ, where
and the prior variance is again assumed as 10 4 . The priors finally adopted for a r ; b r ; a e v 2 and b e v 2 based on these considerations are given in Supplementary Tables S1-5.
Data
Experimental data sets
The first data set is taken from a study (Bert et al., 2013) in which epigenetic differences between a prostate cancer cell line (LNCaP) and normal primary prostate cells (PrEC) were analyzed. Gene transcription was measured on a transcript level by RNA-seq, while Histone H3 lysine K4 trimethylation (H3K4me3) and Histone H3 lysine K27 trimethylation (H3K27me3) were localized by ChIP-seq. The preprocessing follows Klein and Sch€ afer (2016) , leading to normalized TPM values for both ChIP-seq and RNA-seq. For more information on the data see Supplementary Data, Section 1.
The second data set is taken from a study (Hon et al., 2014) in which epigenetic effects in mice were investigated with a focus on the role of the Ten-Eleven-Translocation (Tet) (2016) for both ChIP-seq and RNA-seq, previous preprocessing is described in Hon et al. (2014) . For more information on the data see Supplementary Data, Section 1.
Matching of data sets
Data matching is performed at gene or transcript level, respectively, following Klein and Sch€ afer (2016) insofar applicable. The basic idea is to obtain a measure for the abundance of a gene i or group of genes from RNA-seq data and to assign a ChIP-seq value based on the number of ChIP-seq reads aligned within the genomic region R i of that gene. Here, for the histone modifications H3K4me3 and H3K27me3 that primarily occur at genes' transcriptional start sites (TSSs) we focus on genomic regions centered at the TSSs. H3K4me1 and H3K27ac occur typically at active enhancers, but may also be present near active promoters ('TSS flanking'). Therefore, for each gene i, the genomic region R i for these histone modifications is defined as the union of a region centered at the TSS and regions centered at corresponding enhancers. To determine enhancers and transcripts associated with them, we employed a list of enhancer-promoter units provided by Shen et al. (2012) . Since H3K36me3 occurs primarily throughout gene bodies and shows low abundances near the TSS, the whole gene body is defined as genomic region for that histone modification. More details are given in the Supplement, Section 1. Genomic networks published by Lee et al. (2011) and Kim et al. (2016) are used to define similarity scores x ij for the prostate cancer and Tet2 knockout data sets, respectively. The human network published by Lee et al. (2011) contains 476 399 nodes between 16 243 genes. The x ij take values between 0.405 and 4.257, with an average score of 1.14 and an average number of neighbors of 75.25. The murine network published by Kim et al. (2016) contains 788 080 nodes between 17 714 genes. The x ij take values between 0.741 and 5.361, with an average score of 1.76 and an average number of neighbors of 86.32. In both networks, genes are denoted by their Entrez ID. The genes in the network were matched with the genes in the data set, denoted by their common gene name, by using the BioMart database and keeping only those genes that could be uniquely associated with an Entrez ID, excluding genes without neighbors.
Simulation study
A simulation data set is generated based on 14 700 randomly selected genes from the two wildtype mice replicates of the Tet2 knockout data set. We assume that all genes are neither differential in gene transcription nor in histone modification between the two biological replicates. All genes are assigned to 126 artificial pathways each consisting of either 50, 100 or 200 genes. We simulate three data sets, assuming 18 pathways to consist of differential genes, which are simulated by multiplying the expression value and the four ChIP-seq values of the first replicate by ð1 þ cÞ with c 2 6f0:25; 0:5; 0:75g (data sets 1 and 2) or c 2 6f0:1; 0:2; 0:3g (data set 3). Each pathway corresponds to one of the possible combinations of c values and the number of genes (see Supplementary  Tables S29, S31 and S33 for more details). This leads to 2100 genes with equally directed differences in all five data types. For the first data set, the remaining 108 pathways are assumed to consist of genes with non-consistent differences, simulated by multiplying the values of two randomly selected variables of the first replicate by ð1 þ cÞ and the other three values by ð1 À cÞ with c as above. A functional network is simulated as follows: Within a pathway, 50% of the possible edges are randomly established, while 1=25 of each pathways' nodes are randomly connected via an edge with nodes from other pathways, similar to the simulation done by Tai et al. (2010) .
Results
Markov chains were run in the BUGS software (Thomas, 1994) . Chains were run for 10 million iterations, to which for the Tet2 knockout experimental data a burn-in of 1.3 million was applied. A thinning of 4 000 was applied for all data sets. The high number of iterations was chosen due to the observation of a near-periodicity in the Markov chains for 1=e v 2 for the Tet2 knockout experimental data sets, and for those data sets we achieved convergence by undertaking a simple modification of the chains as proposed in Rosenthal (2003) as Remark 6. Trace plots are documented in Supplementary Figures S2, S4-7 and S10-20.
Prostate cancer data set
Normalized TPM values of LNCaP and PrEC cells were calculated for 113 663 groups of transcripts that share the same TSS based on transcript annotation from the GENCODE project (Harrow et al., 2012) . 19 505 of these (groups of) transcripts show a reasonably strong transcription (TPM values ! 2) in both LNCaP and PrEC and were used for model fitting. Following the strategy proposed in Klein et al. (2014) , for both H3K4me3 and H3K27me3 histone modifications a promoter width of w ¼ 3 000 was chosen by determining at which promoter width an elbow exists in the curve describing the Pearson correlation between differences in gene transcription and differences in histone modification, similar to a scree plot ( Supplementary Fig.  S1 ). After matching with the gene network published by Lee et al. (2011) , 16 156 genes remained in the data set. Transcript-specific estimates are given for selected transcripts in Table 1 , while estimates for transcript-independent parameters are given in Supplementary Table S6 . To ensure a positive sign for the Z i in case of consistent differences in all variables, we chose 
i H3K27me3. In (5), the indicator function needs to be transformed to produce values in {-1,1}. The different sign for H3K27me3 is required in (5) due to the repressive character of this histone mark, as opposed to H3K4me3 which has an activating effect. 6094 transcripts with a mean z i value of 0.79, a mean b l i value of 0.57, a mean number of neighbors of 222.99 and a mean x ij value of 1.17 are identified as differential (see Supplementary Spreadsheet S1). A KEGG pathway analysis of the genes identified as differential (Dennis et al., 2003) was performed as a plausibility check. 58 pathways were enriched (FDR < 0.05), prominently featuring Prostate cancer and several other cancer types as well as further cancer-related functionality such as Cell cycle or Pathways in cancer, but also neurodegenerative disorders (Huntington's disease, Alzheimer's disease, Parkinson's disease) (see Supplementary Spreadsheet S2 for details). A link between cancer and neurodegenerative disorders has been suggested due to shared genes and molecular mechanisms, and individuals affected by a neurodegenerative disease may have a decreased risk of some cancers (Plun-Favreau et al., 2010) .
The transcript achieving the highest b l i was PRUNE2, a tumor suppressor gene in human prostate cancer identified recently (Salameh et al., 2015) . FOXQ1 has been described as a marker for Wnt activation in tumors of different origins (Christensen et al., 2013) . Elevated expression of FAM83B has been associated with elevated tumor grade and decreased overall survival in various cancers (Cipriano et al., 2014) . The adaptor protein AFAP1L2 has been shown to have significant effects in the genesis of different tumors as well, and somatic mutations have been detected in prostate cancer tissues, among others, suggesting a potential as a diagnostic biomarker and therapeutic target for cancer treatments (Bai et al., Note: Shown are model estimates for l i , z i values, numbers of neighbors e n and mean similarity score x ij , ordered by b l i values (top), z i values (middle) or e n i (bottom). The þ=À column indicates whether gene transcription is up-or downregulated according to RNA-seq differences. For model estimates, the posterior mean is reported in addition to the 98% credible interval. 2014). CGREF1 has been reported as up regulated in prostate cancer tissue compared to normal prostate tissue (Balacescu, 2011) .
One might additionally look at the differential transcripts with the highest z i values. The transcript with the highest z i value was CCND2 (z i ¼ 130:59), which has been confirmed to be amplified or overexpressed in various human cancers such as gastric, colorectal, ovarian, testicular, and prostate cancer. Moreover, it has been linked to cell growth and proliferation in prostate cancer (Dong et al., 2010; Zhu et al., 2014) .
A sensitivity analysis found that the influence of the prior variances for 1=e v 2 and 1=r 2 was relatively small. Increasing them from 10 4 to 10 6 , e.g., led to an almost identical number of identified transcripts (6092 instead of 6094).
Tet2 knockout data set
Normalized TPM values of Tet2 knockout and wildtype cells were calculated for 19 989 groups of genes that share the same TSS based on transcript annotation from the GENCODE project (Harrow et al., 2012) . 19 956 of these groups of genes showed a reasonably strong transcription in both Tet2 knockout and wildtype samples (TPM values ! 2) and are used for model fitting. For H3K4me1, H3K4me3 and H3K27ac histone modifications a promoter width of w ¼ 5 000 was chosen, for H3K4me1 and H3K27ac an enhancer width of w ¼ 1 000 was additionally chosen following Figure 1 , respectively. After matching with the gene network of Kim et al. (2016) , 15 130 genes remained in the data set.
Gene-specific estimates are given for selected genes in Table 2 , while estimates for gene-independent parameters are given in Supplementary Table S13 . Here, we chose
with g signðkÞ ¼ signðX H3K36me3. All are activating histone modifications, thus all signs are required to be equal in (6). 86 genes with a mean z i value of À0.16, a mean b l i value of 5.08, a mean number of neighbors of 127.5 and a mean x ij value of 1.64 were identified as differential (see Supplementary Spreadsheet S3).
Tet protein dioxygenases are attributed a mediating role in the regulation of dynamic DNA methylation, particularly in oxidation of cytosine methylation to 5-hydroxymethylcytosine (5hmC) (Tahiliani et al., 2009 ). 5hmC levels have been reported as reduced in human cancers when compared with matched normal tissues, as well as during tumor development in mouse models. A substantial reduction of Tet2 expression is associated, revealing a possible mechanism for the reduced 5hmC in cancer cells (Yang et al., 2013) . In particular, loss of 5hmC is a hallmark of renal cell carcinoma (RCC) (Chen et al., 2016) . The gene with the highest b l i in Table 2 , presenting a a high z i value as well, is L2HGDH. It influences 5hmC accumulation in RCC cells and its expression there reduces histone methylation and suppresses in vitro tumor phenotypes (Shim et al., 2014) .
Again, a sensitivity analysis suggested that the influence of the prior variances for 1=e v 2 and 1=r 2 is small. When increasing them from 10 4 to 10 6 , e.g., the number of identified transcripts was almost identical (89 instead of 86).
Both biological replicates were in addition analyzed separately, i.e. the data set was split into two data sets each consisting of one RNA-seq and four ChIP-seq samples from the knockout and wildtype collective, respectively. Estimates obtained by applying the model to each set of replicates separately are shown in Supplementary Tables S14-17. The Venn diagram of the classification results (Fig. 2) shows that 35 genes were classified as differential in both analyses, while further 9780 genes were classified as differential based on replicate 1 only. The joint analysis, using the mean gene transcription and histone modification values, classified 86 genes as differential, i.e., more than based on replicate 2 but still much less than based on replicate 1. The differences between the two replicates are reflected in the z i values' variability: their standard deviation in replicate 2 is almost four times as high as their standard deviation in replicate 1. The smaller variance in replicate 1 may contribute to a higher number of genes being classified as differential. The rank correlation between the replicate-specific z i values is only 0.075, and in relation to the distributions of the variable-specific components of the z i (Supplementary Fig. S8 ), the Note: Shown are model estimates for l i , z i values, numbers of neighbors e n and mean similarity score differences of these components between replicates are considerable ( Supplementary Fig. S9 ). The specificity of our approach was assessed by using the model to compare the first wildtype replicate to the second wildtype replicate instead of wildtype samples to Tet2 knockout samples (for estimates, see Supplementary Table S18 ). In this setup, no biological differences exist and therefore no genes should be identified by the model. In fact, none of the 15130 genes was identified by the model in this case. When comparing the first knockout replicate to the second knockout replicate, 176 genes were identified as differential (for estimates, see Supplementary Table S19 ). Given the wildtypeonly results, some differences between the knockout replicates could be expected due to the discrepancy between the analyses of replicates 1 and 2. In addition, the standard deviation of the knockout z i values is considerably lower (about 2/3) compared to the wildtype z i , which makes detection of small differences easier in our model.
Simulated data sets
The simulated data sets contain 2100 out of 14 700 genes with equally directed differences in both data types. In the first data set, the equally directed differences are of the same magnitude for all variables. Here, our approach classified 1858 of these genes correctly. 306 genes were falsely classified as differential and 242 genes were falsely classified as non-differential. In summary, a sensitivity of 0.885 and a specificity of 0.976 was observed. We compared our approach to a standard separate analysis of both data types in which the differences X were considered as differentially histone modified, respectively, and the genes in the intersection of these five sets were considered as differential. Figure 3 shows a ROC curve for varying thresholds t, compared to the results obtained from our integrative method. The standard approach, while obtaining an AUC of 0.975, at the same level of specificity achieved a smaller sensitivity of 0.722, probably due to a loss of information caused by the separate analyses. For both approaches, a decrease in effect size led to a reduced sensitivity, while the effect of the pathway size was less clear. Supplementary Table S29 shows that especially for small differences, our approach achieved a notable gain in sensitivity of about 0.4. In two further simulated data sets, equally directed differences were simulated with different magnitudes for the five variables, since some epigenomic measures are not always well-predictive of gene transcription and gene transcription and epigenomic marks are thus sometimes correlated with a varying degree. The two data sets differ regarding the overall magnitude of simulated differences. On both data sets, the standard approach already achieved a good performance (AUC ¼ 0.995 and 0.944, respectively), however, our Bayesian model achieved a higher sensitivity at the same level of specificity in both cases (see Supplementary Tables S31 and S33 ).
Discussion
The results found by our integrative hierarchical Bayesian model MARIO in the analysis of experimental data are consistent with findings reported in biomedical literature. The results from the simulated data sets and from comparing two biological replicates from the Tet2 wildtype data set show that a high specificity is achieved by MARIO when detecting genes with differences in all considered data types. The simulation study additionally gives evidence for a reasonable sensitivity.
Compared to a separate analysis of the different types of genomic data in a simulation study, our integrative approach shows a superior performance. This may be owed to the classification being based on a score aggregating information from all data types, demonstrating the importance of novel integrative methods for studies incorporating more than one genomic data type and additional information. Model-based classification may consume more computing time, but in contrast to standard approaches based, e.g. on fold change rankings, avoids arbitrary thresholds.
Our approach allows to correlate several genomic data types with a binary outcome. Data types are treated equally, and while minor differences exist, our analyses indicate no elevated importance of any particular variable (see Supplementary Figs S3 and S8 ). Although we focus on gene transcription and histone modification data, our approach MARIO is not limited to these data types. Also, if a considerable number of samples were available, an extra model layer might be added to extend the model, modeling the distribution across the samples for a given gene as well.
One might consider to include a non-spatial effect in addition to U i when modeling the gene-specific mean l i . When we assessed such a model in preliminary analyses, the effect was however negligible, i.e. the spatial effect explained virtually all of the variance (see Fig. 3 . ROC based comparison of our method to a standard approach using simulated data. The Bayesian model classified 1858 genes with differences in all five variables correctly as differential. 242 differential genes were falsely classified as non-differential resulting in a sensitivity of 0.885. The observed specificity was 0.976 (triangle). The black curve represents the performance of standard separate analyses of the five variables as described in Section 4.3, with AUC ¼ 0.975. Genes were considered as differential genes if they were detected as differentially expressed and differentially histone modified for all four considered histone modifications and if the differences had the same sign in all data types. At the same level of specificity, the standard approach achieved a lower sensitivity of 0.722
Supplementary Tables S7 and S26 and Supplementary Section 4). This should be different if more samples were modeled. A comparison with analyses based on restricting the integrative score to its gene transcription component shows that integration across several data types may have two consequences: The remaining effects tend to be larger due to multiplication of several singlevariable effects, and may thus tolerate a higher number of neighbors without getting smoothed out. Regarding the number of identified transcripts or genes, two opposite effects may occur: requiring the existence of single-variable effects for a higher number of variables may, intuitively, reduce the number of identified transcripts or genes -this occurs in case of the Tet2 knockout data set, where 14 630 genes are identified as differential for the RNA-seq-only analysis (see Supplementary Table S21 ). However, it may also occur that due to relatively small single-variable effects their multiplication is needed to reach a sufficient magnitude to be identified -this occurs in the case of the prostate cancer data set, where only 7 transcripts are identified as differential for the RNA-seq-only analysis, 6 from the same gene (see Supplementary Table S9) .
For the prostate cancer data set, the b l i take values between À2.591 and 10.790, while in the Tet2 knockout analysis they take values only between 3. 971 and 6.191 . This means that the employed murine network has a considerably stronger smoothing effect than the human network, and it is not able to explain as much variance in the z i values as the human network. The portion of variance explained by the network is reflected in the ratio of the (unconditional) variance of the U i to r 2 , which is much smaller for the Tet2 knockout data set. The employed functional network is thus highly influential on the results. It may also be harder for the murine network to explain the variance because in the Tet2 knockout data set there are more variables to integrate, leading to a less spread out distribution mass in the empirical z i distribution, besides a number of more extreme z i values (the interquartile distance is 0.135 in the prostate cancer data, but only 0.02 in the Tet2 knockout data). Generally, on a gene level, the smoothing effect of the model increases with the number of neighbors, i.e., a growing number of neighbors brings the b l i closer to the overall mean. To further test this observation, we analyzed both the prostate cancer data set and the Tet2 knockout data set with a thinned network by randomly deleting half of all edges (edges connecting nodes having a sole neighbor were excluded from random deletion to maintain the same number of transcripts in the analysis). The estimated l i values tended indeed to be slightly higher than with the original networks (see Supplementary Tables S11 and S23) .
The z i values, on the other hand, do influence the results jointly, while changes (even big changes) in a single z i value may leave the results virtually unaltered. This is a consequence of the employed CAR prior and, e.g., may lead to genes with top b l i values but a small z i value, as occurs in the Tet2 knockout data set. The neighbors' mean z i value dominates in such cases. We therefore suggest to select the network carefully. In an analysis of the Tet2 knockout data set based on a denser network obtained from Guan et al. (2008) with a high average number of neighbors, only 8 genes are identified (see Supplementary Table S25) . If most or all genes were considered as neighbors and differences in functional association were made only regarding the similarity scores, an extremely high smoothing would presumably prevent any detection of genes as differential.
The ranking of genes by their estimated normal means b l i is useful for the prostate cancer data set in which, e.g., the credible interval for the l i of the highest-ranking gene overlaps only with those of 13 further genes. For the Tet2 knockout data set, on the other hand, the credible intervals of all l i credible intervals overlap, complicating the interpretation of the ranking, while the classification of genes as differential or not remains useful. If a less conservative gene prioritizing is desired, the credibility level may be adjusted.
Conclusion
We propose MARIO, a novel hierarchical Bayesian model approach for the parallel, integrative analysis of data from several genomic data types that additionally enables facilitating the incorporation of information from functional genomic networks. The goal is to classify genes as differential or not differential based on a generalized correlation measure for multiple sequencing-based genomic variables. Due to the additional information, MARIO allows to perform inference on the gene level even when the sample size is very small. In an integrative analysis of ChIP-seq and gene transcription data, our approach detected a considerable number of genes for which alterations in gene transcription and several histone modifications exist between two relevant biological conditions. We assessed the sensitivity and specificity of our approach based on simulated data and on biological replicates and demonstrated its superior performance compared to a standard separate analysis approach. Given the increasing availability of functional genomic networks and the fact that modern studies often contain several types of genomic data, the presented method is a useful and important tool for the integrated analysis of such data.
